许益琳, 宋娜, 王晓翠, 禹洋洋. 乳腺癌患者化疗中并发症的临床护理[J]. 实用临床医药杂志, 2019, 23(7): 113-115, 120. DOI: 10.7619/jcmp.201907030
引用本文: 许益琳, 宋娜, 王晓翠, 禹洋洋. 乳腺癌患者化疗中并发症的临床护理[J]. 实用临床医药杂志, 2019, 23(7): 113-115, 120. DOI: 10.7619/jcmp.201907030
XU Yilin, SONG Na, WANG Xiaocui, YU Yangyang. Clinical nursing for complications in breast cancer patients treated with chemotherapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 113-115, 120. DOI: 10.7619/jcmp.201907030
Citation: XU Yilin, SONG Na, WANG Xiaocui, YU Yangyang. Clinical nursing for complications in breast cancer patients treated with chemotherapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 113-115, 120. DOI: 10.7619/jcmp.201907030

乳腺癌患者化疗中并发症的临床护理

Clinical nursing for complications in breast cancer patients treated with chemotherapy

  • 摘要:
      目的  比较乳腺癌患者应用经外周静脉置入中心静脉导管(PICC)和完全植入式静脉输液港(TIVAP)化疗的临床护理效果。
      方法  选取本院乳腺癌化疗患者82例,随机分为PICC组和TIVAP组各41例,2组患者予以相应的护理措施,分析2组患者的疗效及焦虑、抑郁情绪的差异。
      结果  2组患者置管成功率均为100%, PICC组出现并发症较多。治疗前焦虑总分2组比较差异无统计学意义(P>0.05),治疗后焦虑总分较治疗前均显著下降(P < 0.05), 且TIVAP组较PICC组治疗后下降更显著(P < 0.05); 治疗前抑郁总分2组比较差异无统计学意义(P>0.05), 治疗后2组抑郁总分均较治疗前显著下降(P < 0.05), 且TIVAP组较PICC组治疗后下降更显著(P < 0.05)。
      结论  将TIVAP和PICC应用于乳腺癌化疗患者,能够确保患者顺利实施治疗,有效控制患者焦虑、抑郁情绪,且TIVAP较PICC化疗效果更优。

     

    Abstract:
      Objective  To compare the clinical nursing effect of peripherally inserted central venous catheter (PICC) versus totally implantable venous-access ports (TIVAP) in breast cancer patients with chemotherapy.
      Methods  A total of 82 patients with breast cancer treated by chemotherapy in our hospital were randomly divided into PICC group and TIVAP group, with 41 cases in each group. The two groups were given corresponding nursing measures. Anxiety, depression and clinical efficacy were analyzed.
      Results  The success rate of catheterization in the two groups was 100%, but PICC group had more complications. Before treatment, the total anxiety and depression scores in two groups showed no significant differences (P>0.05), were lower after treatment than treatment before, and TIVAP group decreased more significantly than PICC group after treatment(P < 0.05).
      Conclusion  TIVAP and PICC in breast cancer patients with chemotherapy can ensure the smooth implementation of treatment, effectively control the anxiety and depression of patients, and TIVAP has better treatment efficacy than PICC.

     

/

返回文章
返回